Exact Sciences Corporation
Clinical trials sponsored by Exact Sciences Corporation, explained in plain language.
Exact Sciences Corporation
EXAS
NASDAQ
Molecular diagnostics company focused on cancer screening and detection.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Blood test may spot hidden cancer DNA after surgery Results expected May 2027 (estimated)